semaglutide mechanism difference tirzepatide vs Beyond glycemia: Comparing tirzepatide to GLP-1 analogues Semaglutide vs Survodutide: GLP-1 vs
Description
Significance statement ![Figure][1] ### Competing Interest Statement The authors have declared no competing interest
Search to find a Lilly clinical trial near you
Purpose of Review This review explores the rationale and available evidence behind incretin-based therapies for metabolic dysfunction-associated steatotic disease (MASLD) and metabolic-associated steatohepatitis (MASH), focusing on glucagon-like peptide 1 (GLP-1) and glucagon (GCG) receptor dual agonists (GLP-1/GCG RAs)
Notes: Size and dimensions: 29 Gauge 1cc 1/2 inch
